Clinical Trials Update: Sept. 10, 2010 (HealthDay)
Last Updated on Friday, 10 September 2010 11:36 Written by Natural Health Team Friday, 10 September 2010 11:36
of ClinicalConnection.com:
Psoriasis
This study of moderate-to-severe plaque psoriasis will
compare an investigational combination of two FDA-approved drugs with a
single approved psoriasis medication.
The research site is in
Denver, Colo.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/psoriasis.aspx.
—–
Insomnia
To qualify for this study, candidates must be aged 21
to 64, have trouble staying asleep, and be in general good
health.
The research site is in New York City.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/insomnia.aspx.
—–
Hot Flashes
This 12-week study will evaluate the safety and
effectiveness of the study drug in eliminating hot flashes in
post-menopausal women. Participants must be 40 or older and have 50 to 60
hot flashes per week.
The research site is in Sacramento, Calif.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/hot_flashes.aspx.
—–
Copyright 2010 ClinicalConnection.com. All rights reserved.
« Cholera stalks West Africa as rains spread disease (AP) | J&J widens access as cancer drug helps survival (Reuters) »
Loading ...